Ocular drug delivery by liposome–chitosan nanoparticle complexes (LCS-NP)
- 31 March 2007
- journal article
- Published by Elsevier BV in Biomaterials
- Vol. 28 (8), 1553-1564
- https://doi.org/10.1016/j.biomaterials.2006.11.028
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Chitosan Nanoparticles as a Potential Drug Delivery System for the Ocular Surface: Toxicity, Uptake Mechanism and In Vivo ToleranceInvestigative Ophthalmology & Visual Science, 2006
- New Insights into Self-Organization of a Model Lipid Mixture and Quantification of Its Adsorption on Spherical Polymer ParticlesLangmuir, 2005
- Molecular Architecture of Nanocapsules, Bilayer-Enclosed Solid Particles of CisplatinJournal of the American Chemical Society, 2004
- Preparation and stability of lipid-coated nanocapsules of cisplatin: anionic phospholipid specificityBiochimica et Biophysica Acta (BBA) - Biomembranes, 2004
- Comparison of Liposome-Encapsulated Acyclovir with Acyclovir Ointment: Ocular Pharmacokinetics in RabbitsJournal of Ocular Pharmacology and Therapeutics, 2004
- Interaction of polyelectrolyte coated beads with phospholipid vesiclesComptes Rendus Physique, 2003
- Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin AInternational Journal of Pharmaceutics, 2001
- Lipid Coating on Polyelectrolyte Surface Modified Colloidal Particles and Polyelectrolyte CapsulesMacromolecules, 2000
- Impression CytologyCornea, 1988
- Statistical consequences of reducing the number of rabbits utilized in eye irritation testing: Data on 67 petrochemicalsToxicology and Applied Pharmacology, 1984